Descripción del título
Medication development for ...
Monografía
monografia Rebiun33421257 https://catalogo.rebiun.org/rebiun/record/Rebiun33421257 m o d f cr bn||||||abp cr bn||||||ada 100519s1997 mdua ob f100 0 eng d 434071527 502999907 649899167 1049667364 1057096381 UPVA 998316016703706 017-024-01612-8 GPO OCLCE eng pn OCLCE CSO OCLCQ OCLCO OCLCQ OCLCO OWS OCLCF OCLCO INARC WUM XFF BGU OCLCA OCLCQ OCLCO OCL dlr Medication development for the treatment of cocaine dependence issues in clinical efficacy trials editors, Betty Tai, Nora Chiang, Peter Bridge Rockville, MD U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications [Washington, D.C.] [Supt. of Docs., U.S. G.P.O., distributor] 1997 Rockville, MD [Washington, D.C.] Rockville, MD U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications [Washington, D.C.] [Supt. of Docs., U.S. G.P.O., distributor] 1 online resource (iv, 329 pages) illustrations 1 online resource (iv, 329 pages) Text txt rdacontent computer c rdamedia online resource cr rdacarrier NIDA research monograph 175 NIH publication no. 98-4125 "Based on the papers from a technical review ... held on October 20-21, 1994"--Page ii Shipping list no.: 98-0092-P Includes bibliographical references Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research -- Overview of potential treatment medications for cocaine dependence -- Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective -- Management of clinical trials with new medications for cocaine dependence and abuse -- Outcome measurement considerations: pharmacological treatments for substance abuse -- Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials --Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence -- Addiction severity index in clinical efficacy trials of medications for cocaine dependence -- Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment -- Treatment effectiveness score as an outcome measure in clinical trials -- Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis -- Quantitative urine levels of cocaine and other substances of abuse -- Use of quantitative urinalysis in monitoring cocaine use -- Is quantitative urinalysis more sensitive? -- Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine -- Appendix I: Workshop summary outcome measures and success criteria -- Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy Use copy. Restrictions unspecified star. MiAaHDL Electronic reproduction. [Place of publication not identified] HathiTrust Digital Library 2010. MiAaHDL Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL Cocaine abuse- Chemotherapy- Congresses Cocaine abuse- Treatment- Congresses Clinical trials- Congresses Cocaine Drug testing Cocaine Cocaine-Related Disorders- drug therapy Clinical Trials as Topic Drug Evaluation Substance Abuse Detection Cocaïnomanie- Chimiothérapie- Congrès Cocaïnomanie- Traitement- Congrès Études cliniques- Congrès Cocaïne Toxicomanie- Dépistage Drug testing. Cocaine. Clinical trials. Cocaine abuse- Treatment. Congress Online book Conference papers and proceedings. Conference papers and proceedings. Actes de congrès. Tai, Betty Chiang, C. Nora Bridge, Peter M.D. National Institute on Drug Abuse. Office of Science Policy and Communications Print version Medication development for the treatment of cocaine dependence. Rockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ; [Washington, D.C.] : [Supt. of Docs., U.S.G.P.O., distributor], 1997 (DLC) 98110039 (OCoLC)38160933 NIDA research monograph 175 NIH publication no. 98-4125